AndhraNews.net
Home » Features » Health » Tuberculosis

Tuberculosis


About Tuberculosis

Tuberculosis tests

Tuberculosis in News

Menssana Research Breath Test Predicts Lung Cancer
NEWARK, NJ--(Marketwired - December 23, 2015) - An advanced new breath test accurately predicted lung cancer in a blinded clinical study.

Novartis announces Phase III studies of Jakavi show disease improvement in patients with myelofibrosis and polycythemia vera
Novartis International AG /Novartis announces Phase III studies of Jakavi show disease improvement in patients with myelofibrosis and polycythemia vera . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Molecular Diagnostics Market Worth $9.50 Billion by 2022: Grand View Research, Inc.
The global molecular diagnostics market is expected to reach over USD 9.50 billion by 2022, according to a new report by Grand View Research Inc. Growing prevalence of chronic diseases and infections such as HPV and influenza is anticipated to be the key driver for molecular diagnostics market growth

Danny Aiello, Nancy Kerrigan, Brian Boitano and Johnny Weir Star in Tree Lighting Skate-tacular at Bank of America Winter Village at Bryant Park
NEW YORK, NY--(Marketwired - November 17, 2015) - Olympic figure skaters Nancy Kerrigan, Brian Boitano, Johnny Weir and Davis & White will star in the first-ever performance of an original theatrical ice production narrated by legendary actor and native New Yorker, Danny Aiello, at 6:00 p.m. on December 1, 2015 in Bryant Park.

Tax Unhealthy Food to Help Prevent Type 2 Diabetes
415 million adults have diabetes, with an additional 318 million at risk according to new data released by the International Diabetes Federation (IDF) at a World Diabetes Day event in Brussels today. IDF estimates that most countries spend 5%-20% of their healthcare budget on diabetes, a disease which can cause blindness, cardiovascular, kidney and nerve disease

Salar Ahmed Khan Is Presented the Award of Distinction by the International Assoc. of Who's Who
Dr. Salar Ahmed Khan has been a Research Compliance Officer with the Jesse Brown Veterans Affairs Medical Center (JBVAMC) in Chicago, Illinois since 2009, although he has been with the organization since October 2000, in the Research and Development Department.

New Colombia Resources to Apply for an Orphan Drug Designation With the FDA for a Medical Marijuana Pharmaceutical Drug to Treat a Rare Pediatric Disease
New Colombia Resources, Inc.(OTC PINK: NEWC) ("New Colombia" or the "Company"), a U.S

Reduce Exposure to Tuberculosis With RxAir UV Light Air Purification
Healthcare professionals are concerned about recent increases in tuberculosis (TB) cases across the US because individuals with weakened immune systems, such as from diabetes, are highly susceptible to infections and complications

World Exclusive: China's Renowned Soprano and First Lady Peng Liyuan Officially Takes Up Residence at Madame Tussauds Hong Kong
Madame Tussauds Hong Kong today announced the official arrival of Peng Liyuan, renowned soprano, performing artist and "China's First Lady." Her wax figure can now be found at the attraction's "Historical and National Heroes" themed area, along with the wax figures of various world leaders and historical heroes.

Regulatory Update: GSK and Theravance Announce Intention to File Relvar(R) Ellipta(R) for COPD in Japan
GlaxoSmithKline (LSE: GSK) (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the intention to file a supplemental Japanese New Drug Application (sJNDA) for Relvar® Ellipta® (fluticasone furoate "FF"/vilanterol "VI" or "FF/VI") for the treatment of chronic obstructive pulmonary disease (COPD) with the Japanese regulatory authority during the first quarter of 2016

GSK and Theravance Announce Results From the SUMMIT COPD CV Survival Study
GlaxoSmithKline plc (LSE: GSK) (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced initial results from the Study to Understand Mortality and MorbidITy in COPD (SUMMIT) for Relvar®/Breo® Ellipta® 100/25mcg (fluticasone furoate 'FF'/vilanterol 'VI' or 'FF/VI')

Helix BioPharma Corp. Announces Upcoming Presentation of L-DOS47 at World Conference on Lung Cancer
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced that an abstract for its lead lung cancer candidate L-DOS47 has been selected for oral presentation at the 16th World Conference on Lung Cancer (WCLC) held in Denver, Colorado, September 6-9, 2015.

SomaLogic and Otsuka Pharmaceutical Extend Research Collaboration for Therapeutic SOMAmer(R) Development
BOULDER, CO--(Marketwired - August 10, 2015) - SomaLogic, Inc., announced today that Otsuka Pharmaceutical Co., Ltd. has extended its initial collaboration agreement with SomaLogic to continue the development of several SOMAmer® therapeutics. Specific projects and financial terms in the extended agreement were not disclosed.

Cellceutix Provides Insights to Its Four Clinical Trials for the Treatment of ABSSSI (Completed Phase 2), Anti-Cancer (Phase 1), Psoriasis (Phase 2), and Oral Mucositis in Head and Neck Cancer Patients (Phase 2)
BEVERLY, MA--(Marketwired - August 07, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, would like to address shareholders with recent events concerning Cellceutix.

Nu-Med Plus Announces New Methodology Using Nitric Oxide for Diabetic Wound Healing
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced today that it has created the design and methodology by which Nitric Oxide (NO) may well be safely delivered, at optimal levels, to facilitate in the therapeutic healing of chronic diabetic foot ulcers and wounds.

Indiana Tuberculosis Outbreak Victims File Class Action Complaint

Novartis announces data show majority of patients with polycythemia vera treated with Jakavi® achieved long-term disease control
Novartis International AG /Novartis announces data show majority of patients with polycythemia vera treated with Jakavi® achieved long-term disease control . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Portea Medical Acquires MedybizPharma to Accelerate Penetration into India's Chronic Disease Market
Business Wire IndiaPortea Medical, India’s largest home healthcare company, today announced that it has acquired specialty pharmaceutical distributor MedybizPharma in a move that will enable Portea to strengthen patient engagement and provide better care for chronic disease patients in India.   The acquisition was made for an undisclosed consideration of cash and stock

National NGO Working Towards Inclusiveness, Helps Nepal Earthquake Victims
Business Wire IndiaNational Organisation for Social Empowerment or commonly known as National NGO has been in news a lot recently. With its collective vision of ‘Inclusiveness’, the NGO has been helping people, particularly PWDs. It also had a part in rehabilitating the victims of the massive Nepal earthquake

Takeda Joins WIPO Re:Search to Accelerate R&D of New Drugs for Neglected Tropical Diseases, Malaria and TB
Business Wire IndiaTakeda Pharmaceutical Company Limited (TOKYO:4502) today announced its participation in WIPO Re:Search, a consortium to accelerate research and development (R&D) of new drugs, vaccines, and diagnostics for neglected tropical diseases, malaria and tuberculosis (TB)

Novartis announces safety and efficacy benefit of Jakavi® in global clinical trial of over 1,000 patients with myelofibrosis
Novartis International AG /Novartis announces safety and efficacy benefit of Jakavi® in global clinical trial of over 1,000 patients with myelofibrosis . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Sierra Leone Pilot Study of 10 Minute Ebola Rapid Test Shows Promise
Medical diagnostic manufacturer JAJ International, Inc. (www.jajinternational.com) a subsidiary of LuSys Laboratories, Inc., receives promising results from a Sierra Leone Pilot Study for their Point of Care 10 Minute Ebola Rapid Test Diagnostic.

aden + anais(R) Announces a Special Edition Designer Collection for (aden + anais)RED
NEW YORK, NY--(Marketwired - December 01, 2014) - Global baby brand aden + anais® and (RED)® today announced a designer collaboration with Jessica Alba, Gwen Stefani and Rachel Zoe for a limited edition organic swaddle pack to benefit the Global Fund and empower parents to take action towards an AIDS-free generation

Bank of America Winter Village at Bryant Park Goes (RED) for the Annual Tree Lighting
NEW YORK, NY--(Marketwired - November 24, 2014) - Bank of America Winter Village at Bryant Park will dedicate its annual holiday tree lighting to the fight to eradicate mother-to-child HIV transmission

Media Pioneer Ted Turner Receives James C. Morgan Global Humanitarian Award at The Tech Awards
SAN JOSE, CA--(Marketwired - November 14, 2014) - Ted Turner, the visionary and entrepreneur who revolutionized the telecommunications industry, founded CNN and the United Nations Foundation, and serves as Chairman of The Turner Foundation, received the James C

Medicare Costs Analysis Indicates Need for Decreasing Use of Biopsies as Diagnosis Tool for Lung Cancer
CHICAGO, IL--(Marketwired - October 30, 2014) - Biopsies were found to be the most costly tool prescribed in lung cancer diagnosis, according to research presented today at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology

Awarepoint Webinar to Explain How RTLS Technology Permits Rapid Tracking of Infection Exposure
Awarepoint Corporation, the largest real-time location system (RTLS) provider dedicated exclusively to healthcare, today announced it will present a webinar entitled Using Real-time Location System Technology to Track Infection Exposure on Thursday, October 30th, 2014

Doing Well by Doing Good
(Family Features) Beyond their bottom lines, a growing number of companies and brands are harnessing their products, services and resources to help make the world a better place.

GeoVax's Chief Scientific Officer Featured as Lecturer at American Society for Microbiology Conference
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing HIV/AIDS vaccines, today announced that its Chief Scientific Officer, Harriet L. Robinson, Ph.D., presented a virtual lecture entitled "Working Towards an HIV Vaccine," on August 29, 2014 at the African Center for Integrated Laboratory Training in Sandringham, South Africa, sponsored by the American Society for Microbiology.

Novartis provides drug candidate compounds to TB Alliance
Novartis International AG /Novartis provides drug candidate compounds to TB Alliance. Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Global PCR Technologies Market - Forecast to 2019
Research and Markets (http://www.researchandmarkets.com/research/8t3dsp/pcr_technologies) has announced the addition of the "PCR Technologies Global market - Forecast to 2019" report to their offering.

Theravance Reports Second Quarter 2014 Financial Results
Theravance, Inc. (NASDAQ: THRX) today reported financial results for the quarter ended June 30, 2014 and announced that its Board of Directors approved a $0.25 per share cash dividend to be paid on September 18, 2014 to stockholders of record as of the close of business on August 28, 2014. Royalties earned in the second quarter of 2014 were $3

Epistem Plc: Announcement of Collaborative Funding Agreement With Global Health Investment Fund I, LLC

Stratos Product Development & Intellectual Ventures Receive 2014 R&D 100 Award
Stratos Product Development today announced it is a recipient of a 2014 R&D 100 Award for work on Intellectual Ventures' Passive Vaccine Storage Device. Stratos provided design and development services for the device that is currently being used in Africa to deliver life-saving vaccines to thousands of children

GSK and Theravance Announce Submission to US Regulatory Authorities for Fluticasone Furoate/Vilanterol in Asthma
GlaxoSmithKline plc (LSE: GSK) (NYSE: GSK) and Theravance, Inc

Otsuka Pharmaceutical to Acquire Avanir Pharmaceuticals
Otsuka Pharmaceutical Co., Ltd. is pleased to announce an agreement with Avanir Pharmaceuticals, Inc. (“Avanir”) in which Otsuka America, Inc., a US subsidiary, acquires Avanir for USD 3.5 billion in an all-cash tender offer. The contract was signed on December 2, Japan time.

Coca-Cola Invites the World to “SHARE THE SOUND OF AN AIDS FREE GENERATION” and Support (RED)
The Coca-Cola Company, in partnership with (RED), invites people from all over the world to join efforts to help end mother-to-child transmission of HIV with the launch of a new campaign, titled “SHARE THE SOUND OF AN AIDS FREE GENERATION”

BioNet Appoints New COO and Accelerates the Development of New Recombinant Pertussis Vaccine
BioNet-Asia, a vaccine company focused on vaccine discovery and supply, announced that Georges Thiry has been appointed COO of the company, effective early 2015.

AHF India Urges Prime Minister Modi to Restore Drug Price Caps
AIDS Healthcare Foundation (AHF), the largest global AIDS organization, with its affiliate country program, AHF India, has urged Indian Prime Minister Narendra Modi to restore drug pricing caps in India that he recently overturned, a move that advocates fear will make making lifesaving medicines less affordable in that country.

International SOS Continues to Advise Clients during “Unprecedented” Ebola Outbreak
81% of calls to International SOS on Ebola came in July / August Nigeria most discussed country in relation to Ebola Ebola planning and training services are available International SOS continues to provide expert advice to client organisations during the ongoing Ebola outbreak

GSK and Theravance Announce Positive Results From Pivotal Phase III Study for Fluticasone Furoate/Vilanterol in Asthma
GlaxoSmithKline (GSK) and Theravance, Inc. (NASDAQ: THRX) today announced positive results from a phase III efficacy and safety study of fluticasone furoate "FF"/vilanterol "VI" designed to support a potential filing for an asthma indication for adults in the US.

Novartis to highlight long-term data, innovative pipeline for patients with hematologic diseases and breast cancer at ASH and SABCS
Novartis International AG /Novartis to highlight long-term data, innovative pipeline for patients with hematologic diseases and breast cancer at ASH and SABCS . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

RELVAR(R) ELLIPTA(R) Receives European Marketing Authorisation for the Treatment of Asthma and COPD
GlaxoSmithKline plc (GSK) and Theravance, Inc. (NASDAQ: THRX) announced today that the European Commission has granted marketing authorisation for RELVAR® ELLIPTA®, which is now licensed across 31 European countries for the following uses:

FDA Grants QIDP Designation to The Medicines Company's Investigational Antibiotic Oritavancin
The Medicines Company (NASDAQ: MDCO) today announced that the U.S. Food and Drug Administration (FDA) has designated oritavancin as a Qualified Infectious Disease Product (QIDP)

Official Roster of Teams Announced in the $10 Million Qualcomm Tricorder XPRIZE
XPRIZE today announced the 34 registered teams competing for the Qualcomm Tricorder XPRIZE, a 3.5-year global competition sponsored by the Qualcomm Foundation that will award $10 million to teams that develop a consumer-friendly, mobile device capable of diagnosing and interpreting a set of 15 conditions and capturing vital health metrics

BREO(R) ELLIPTA(TM) Now Available in the U.S. for the Treatment of COPD
GlaxoSmithKline plc (LSE: GSK) (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that BREO ELLIPTA, a once-daily prescription medicine for chronic obstructive pulmonary disease (COPD), is now available to pharmacies throughout the U.S.

MYOS Research to Be Presented at International Conference on Sarcopenia and Cachexia
MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of products that improve human muscle health and performance ("MYOS"), today announced that it has been selected to present research at the 7th International Conference of the Society on Sarcopenia, Cachexia, and Wasting Disorders to be held December 9th - 11th, 2013 in Kobe Japan

Theravance Reports Third Quarter 2013 Financial Results
Theravance, Inc. (NASDAQ: THRX) (the "Company") reported today its financial results for the quarter ended September 30, 2013. Revenue for the third quarter of 2013 was $0.4 million. Net loss for the third quarter of 2013 was $47.0 million or $0.44 per diluted share. Cash and cash equivalents, short-term investments and marketable securities totaled $594.5 million as of September 30, 2013.

Insmed Completes Enrollment of Phase 2 Clinical Trial of ARIKACE to Treat Nontuberculous Mycobacteria Lung Disease in U.S. and Canada

Helix BioPharma Corp. Completes Data Review of First Four Cohorts of Its Phase I/II Clinical Study for Lung Cancer Drug Candidate L-DOS47
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has completed its interim review of the Company's ongoing Phase I/II clinical safety, tolerability and preliminary efficacy study of L-DOS47 in Poland (the "LDOS002 Study")

GlobeImmune Announces Milestone Payment for Initiation of Phase 2 Clinical Trial for GS-4774 (Formerly GI-13020) in Patients with Chronic Hepatitis B Virus Infection
LOUISVILLE, Colo., October 15, 2013 - GlobeImmune, Inc., today announced that it has earned a milestone payment from Gilead Sciences, Inc

Helix BioPharma Corp. Initiates Enrollment for Fifth Cohort in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced the opening of patient screening for the fifth dose level cohort in its ongoing Phase I/II clinical safety, tolerability and preliminary efficacy study of L-DOS47 in Poland

Q&A With Chairman and CEO of Aethlon Medical (OTCQB: AEMD) Discussing Launch of New Subsidiary, Exosome Sciences, Inc.
Investorideas.com, an investor research portal specializing in investing ideas in leading sectors including biotech and medical technology stocks, issues an exclusive Q&A with Jim Joyce, Chairman and CEO of Aethlon Medical, Inc. (OTCQB: AEMD). Mr. Joyce discusses the recent launch of its new Exosome Sciences, Inc. (ESI) and what that potentially represents to Aethlon and its shareholders.

RELVAR(TM) ELLIPTA(TM) Gains Approval in Japan for the Treatment of Asthma
GlaxoSmithKline plc (LSE: GSK) (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved RELVAR™ ELLIPTA™ for the treatment of bronchial asthma (in cases where concurrent use of inhaled corticosteroid and long-acting inhaled beta2 agonist is required)

RELVAR(TM) ELLIPTA(TM) Receives Positive Opinion From the CHMP in Europe for the Treatment of Asthma and COPD
GlaxoSmithKline plc (NYSE: GSK) (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending marketing authorisation for fluticasone furoate/vilanterol (FF/VI) under the proposed brand name RELVAR™ ELLIPTA™ for;

Coca-Cola and (RED) Join Forces to Inspire People to Move for the Movement to Help Deliver an AIDS-Free Generation
Your favorite dance move could help save lives. Coca-Cola and (RED) have enlisted the help of Harry Shum, Jr

Oral Apremilast Monotherapy Demonstrated Long-Term Clinical Benefits in Psoriatic Arthritis Patients Naïve to Previous DMARD Therapy

Ross University School of Veterinary Medicine Appoints Senior Scientist to Research Department
Michel Vandenplas, PhD, an accomplished biologist and equine medicine specialist, has joined Ross University School of Veterinary Medicine (RUSVM) as a senior scientist in the research department

Oral Apremilast Demonstrated Long-Term Clinical Benefits for Patients with Psoriatic Arthritis

Xcode Wins $30,000 Grant for Improving Medication Adherence and Saving Lives through Technological Innovation
Xcode Life Sciences, a Chennai-based biotechnology start-up, today announced that they received a $30,000 grant from The Grand Challenges in Tuberculosis Control (GC-TBC) program to deliver an out-of-the-box mobile innovation to enhance TB medication adherence

Clinical Update: Helix BioPharma Corp. Completes Enrollment in First Cohort and Initiates Second Cohort in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, announced the opening of patient screening for the second dose level cohort in its ongoing Phase I/II clinical safety, tolerability and preliminary efficacy study of L-DOS47 in Poland

Two-year data show new Novartis drug Jakavi® significantly reduced myelofibrosis disease burden and suggest overall survival advantage
Novartis International AG /Two-year data show new Novartis drug Jakavi® significantly reduced myelofibrosis disease burden and suggest overall survival advantage . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

Novartis highlights key data in patients with hematologic diseases and breast cancer with more than 140 abstracts at ASH and SABCS
Novartis International AG /Novartis highlights key data in patients with hematologic diseases and breast cancer with more than 140 abstracts at ASH and SABCS . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

vRad Wins Minnie Award for "Most Effective Public Service Campaign"
Virtual Radiologic (vRad), a technology-enabled national radiology practice and the largest telemedicine company in the world, announced today that it has won the 2012 Minnie Award for the "Most Effective Public Service Campaign." The award, which is part of the annual Minnies event sponsored by radiology portal AuntMinnie

Veredus Laboratories Launches Powerful Multiplexed Molecular Diagnostic Lab-on-Chip Targeting Global Threat of Multi-Drug-Resistant Tuberculosis
Singapore, November 7, 2012 - Veredus Laboratories, a leading supplier of innovative molecular diagnostic tools, has launched VereMTBTM, a multiplexed molecular diagnostic chip capable of fast and accurate detection of Mycobacterium Tuberculosis Complex (MTBC) and its mutations, as well as 9 other clinically relevant non-tubercular mycobacterium

"Darling" Is Brad C. Hodson's Skin-Crawling Page-Turner That Will Give Horror Fans the Creeps
"Darling" is the haunting first novel of acclaimed writer Brad C. Hodson, who has honed his craft and passion for horror through a successful track record of popular fiction and non-fiction short stories. Published by Bad Moon Books ($18.95, www.darlingbook.com) in October 2012, "Darling" is sure to spook, haunt and thrill legions of horror story genre fans.

Helix BioPharma Corp. Announces First Patient Enrolled and First Dose Administered in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("HBP"), a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, today announced that the first patient has been enrolled and first dose administered in its ongoing Phase I/II clinical safety, tolerability and preliminary efficacy study of L-DOS47 in Poland.

Hospital-Acquired Infections Diagnostics Market Grew 10% in 2011: Kalorama
The growing focus on hospital-acquired infections (HAI) as a driver of costs and negative outcomes is increasing demand for diagnostic products that can help hospitals and nursing homes decide which patients need treatment and possible isolation

Novartis drug Jakavi® first medication to receive European Commission approval to treat patients with myelofibrosis
Novartis International AG /Novartis drug Jakavi® first medication to receive European Commission approval to treat patients with myelofibrosis . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

Crucell and Scripps Research Discover and Describe Broad-spectrum Antibodies against Influenza B, a Crucial Link in Development of Universal Flu Therapies and Vaccine
In a landmark discovery, researchers from Crucell Holland B.V. and The Scripps Research Institute, today announced the identification of the first human monoclonal antibodies that appear capable of disabling all influenza B viruses. The discovery, published today in the journal Science, addresses a significant missing link in development of universal therapies and a vaccine

Announcement of TB Partnership with Becton Dickinson for the Supply and Distribution of Genedrive(TM) Molecular Point of Care Platform
Epistem ("Epistem" or "the Company") (AIM: EHP), the biotechnology and personalised medicine company, has announced that it has reached agreement with Becton Dickinson (BD) for the supply and distribution of its Mycobacterium tuberculosis (TB) test on a global basis (excluding India and the Indian Sub Continent) using its Genedrive™ platform

TNI BioTech, Inc. Announces Memorandum of Agreement With GB Oncology and Imaging Group LTD
TNI BioTech, Inc. (PINKSHEETS: TNIB) took a major step forward in signing a Memorandum of Agreement with GB Oncology and Imaging Group LTD. ("GB") to equip and operate oncology and infectious diseases clinics in Equatorial Guinea.

Seegene to Unveil Groundbreaking Technology for Highly Multiplexed Quantitative Real-Time Molecular Assays at AACC 2012
Seegene Inc., (096530.KQ) has announced today that it will fully disclose its latest technology, quantitative Tagging Oligonucleotide Capture and Extension (qTOCE™) at the 2012 American Association of Clinical Chemistry (AACC) annual meeting, to be held in Los Angeles, from July 17-19

Seegene to Introduce Real-Time Multiple Mutation Detection Technology for Drug Resistant Mutations in M. tuberculosis at AACC 2012
Seegene Inc., (KOSDAQ: 096530), a leading developer of multiplex molecular diagnostic technologies and tests, today announced that it will introduce Quantplex™ MTB/MDR/XDR Detection, a real time test that detects Mycobacterium tuberculosis and resistance mutations associated with multiple drug resistant (MDR) and extensively drug resistant (XDR) forms of M

'The Great Bare' Breathes Life Into America's First Great Diva
Michael and Barbara Foster's new book, "A Dangerous Woman: The Life, Loves, and Scandals of Adah Isaacs Menken" (Lyons Press), www.TheGreatBare.com, tells the story of the pioneer who forged the way for the likes of Betty Grable and Marilyn Monroe.

Emerald Bio Announces Unprecedented Multi-Target 3D Structural Biology Success
Emerald Bio announces early delivery of the 500th novel protein structure under the Seattle Structural Genomics Center for Infectious Disease (SSGCID), a consortium of researchers from Seattle Biomedical Research Institute (Seattle BioMed), Emerald Bio, the University of Washington and Pacific Northwest National Laboratory (PNNL)

GSK Announces further Initiatives to Advance Openness and Collaboration to Help Tackle Global Health Challenges

Yum! Brands, KFC, Pizza Hut and Taco Bell Launch Annual World Hunger Relief Effort with Global Spokesperson Christina Aguilera Using Her Voice for Good in New Public Service Announcement
Yum! Brands (NYSE: YUM), the world’s largest restaurant company and parent of KFC, Pizza Hut and Taco Bell, announced today the launch of its annual World Hunger Relief effort featuring multi-Grammy Award winner and international superstar Christina Aguilera in a new public service announcement

The New England Journal of Medicine Publishes Efficacy Results of Otsuka's Delamanid for Multidrug-Resistant Tuberculosis
Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced clinical trial results on the safety and efficacy of delamanid, the company's investigational compound for the treatment of multidrug-resistant tuberculosis (MDR-TB), published in the New England Journal of Medicine (available online at http://www.nejm.org/doi/full/10

Pathogens' protein structures offer blueprint for new drugs
Scientists say that they have reached a significant milestone by determining 1,000 protein structures from infectious disease organisms.

Oz's most famous cancer survivor was 'wrongly diagnosed'
Alternative therapies guru Ian Gawler who have claimed for 30 years to have cured himself from secondary cancer might not have had the disease and could have been wrongly diagnosed, a new report has claimed.

Cod liver oil helped combat TB in the past century
The widespread use of cod liver oil encouraged by doctors could have played a significant part in the decline of tuberculosis cases in the late 19th and early 20th centuries, a new study has suggested.

Speedy drug metabolism makes some TB patients resistant to treatment
Scientists including one of an Indian origin have found that multidrug-resistant tuberculosis (TB) is more likely caused in patients by speedy drug metabolism rather than inconsistent doses, as is widely believed.

Vaccine targeting latent TB enters 1st phase of clinical testing
Statens Serum Institut and Aeras have announced the initiation of the first Phase I clinical trial of a new candidate TB vaccine designed to protect people latently infected with TB from developing active TB disease.

A Plea from Civil Societies in India on behalf of the Millions Affected by TB: Do Not Withdraw your Support to Saving Lives
The Global Fund to Fight AIDS, Tuberculosis and Malaria has been a key partner in the world’s fight against TB, a killer disease that continues to take millions of lives despite being curable. In India, this is especially true

Rolling out their breathe in 'beedis'

Tibetan PM-in-Exile launches film on drug abuse, TB in Dharamshala
The Prime Minister of the Tibetan Government-in-Exile, Lobsang Sangay, has launched 'Kyema', a film made to spread awareness among the Tibetan community on drug abuse and Pulmonary Tuberculosis (TB).

PLHIV ask Parliamentary Health Committee Members to ensure Universal Provisions for access to Food Security under the Right to Food Bill and to set up a Focused Parliamentary Committee on TB to better handle the TB/HIV Co-infection

Brangelina to open AIDS clinic in daughter Zahara's native nation Ethiopia
Angelina Jolie and Brad Pitt will be opening an AIDS clinic in their adopted daughter Zahara's native country Ethiopia to ensure that she is always in touch with her African roots.

Quintiles Expands World’s Largest CAP-Accredited Lab Network
Continuing the expansion of its Global Laboratories’ capabilities and resources, Quintiles today announced the opening of a new, expanded central lab in Centurion, South Africa, further adding to its world-leading network of fully harmonized, College of American Pathologists (CAP)-accredited central labs.

Comment on this story

Share